CONCORDIA RX Trademark
Trademark Overview
On Tuesday, August 16, 2016, a trademark application was filed for CONCORDIA RX with the United States Patent and Trademark Office. The USPTO has given the CONCORDIA RX trademark a serial number of 87140304. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 6, 2024. This trademark is owned by Concordia Pharmaceuticals Inc., S.à.r.L. The CONCORDIA RX trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
a full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, irritable bowel syndrome (irritable colon, spastic colon, mucous colitis), acute enterocolitis, and duodenal ulcer; anti-inflammatory medicines and immunosuppressive agents (corticosteroids)
Surgical apparatus and instruments for use in surgery; medical apparatus and instruments for use in treating medical conditions, namely, cancer and symptoms related to cancer
General Information
Serial Number | 87140304 |
Word Mark | CONCORDIA RX |
Filing Date | Tuesday, August 16, 2016 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Friday, December 6, 2024 |
Registration Number | 5472525 |
Registration Date | Tuesday, May 22, 2018 |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, March 6, 2018 |
Trademark Statements
Description of Mark | The mark consists of a coin bearing the image of a Roman goddess next to the words "CONCORDIA RX", wherein both terms share a common "R" and the "X" is formed by the rightmost leg of the "R" and a diagonal line crossing it. |
Goods and Services | a full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, irritable bowel syndrome (irritable colon, spastic colon, mucous colitis), acute enterocolitis, and duodenal ulcer; anti-inflammatory medicines and immunosuppressive agents (corticosteroids) |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Surgical apparatus and instruments for use in surgery; medical apparatus and instruments for use in treating medical conditions, namely, cancer and symptoms related to cancer |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, December 6, 2024 |
Primary Code | 005 |
First Use Anywhere Date | Tuesday, September 30, 2014 |
First Use In Commerce Date | Tuesday, September 30, 2014 |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, December 6, 2024 |
Primary Code | 010 |
First Use Anywhere Date | Saturday, November 30, 2013 |
First Use In Commerce Date | Saturday, November 30, 2013 |
Trademark Owner History
Party Name | Concordia Pharmaceuticals Inc., S.à.r.L |
Party Type | 30 - Original Registrant |
Legal Entity Type | 11 - Company |
Address | Luxembourg L-1610 LU |
Party Name | Concordia Pharmaceuticals Inc., S.à.r.L |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 11 - Company |
Address | Luxembourg L-1610 LU |
Party Name | Concordia Pharmaceuticals Inc., S.à.r.L |
Party Type | 10 - Original Applicant |
Legal Entity Type | 11 - Company |
Address | Luxembourg L-1610 LU |
Trademark Events
Event Date | Event Description |
Friday, August 19, 2016 | NEW APPLICATION ENTERED |
Friday, August 19, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Saturday, August 20, 2016 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Monday, November 28, 2016 | ASSIGNED TO EXAMINER |
Tuesday, November 29, 2016 | NON-FINAL ACTION WRITTEN |
Tuesday, November 29, 2016 | NON-FINAL ACTION E-MAILED |
Tuesday, November 29, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, May 30, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, June 28, 2017 | ASSIGNED TO LIE |
Monday, July 3, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, July 3, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, July 21, 2017 | NON-FINAL ACTION WRITTEN |
Friday, July 21, 2017 | NON-FINAL ACTION E-MAILED |
Friday, July 21, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, January 19, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, January 24, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, January 24, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, January 26, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, February 14, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, March 6, 2018 | PUBLISHED FOR OPPOSITION |
Tuesday, March 6, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, May 22, 2018 | REGISTERED-PRINCIPAL REGISTER |
Wednesday, September 12, 2018 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Wednesday, June 9, 2021 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Monday, May 22, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Friday, December 6, 2024 | CANCELLED SEC. 8 (6-YR) |